• LAST PRICE
    38.5805
  • TODAY'S CHANGE (%)
    Trending Up1.0105 (2.6896%)
  • Bid / Lots
    38.5800/ 2
  • Ask / Lots
    38.6900/ 2
  • Open / Previous Close
    37.6000 / 37.5700
  • Day Range
    Low 37.2200
    High 39.3600
  • 52 Week Range
    Low 14.6535
    High 41.3900
  • Volume
    445,355
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 37.57
TimeVolumeXENE
09:32 ET347037.67
09:34 ET10437.645
09:36 ET40037.37
09:38 ET84737.22
09:41 ET55037.34
09:43 ET1178637.875
09:45 ET388638.05
09:48 ET210238
09:50 ET275837.985
09:52 ET589138.335
09:54 ET420538.205
09:56 ET1980938.73
09:57 ET750738.445
09:59 ET373038.6374
10:01 ET462738.42
10:03 ET255638.6901
10:06 ET40038.74
10:08 ET423738.84
10:10 ET1023638.95
10:12 ET260039.1
10:14 ET271739.12
10:15 ET1336638.99
10:17 ET672438.635
10:19 ET454138.84
10:21 ET207938.82
10:24 ET216238.835
10:26 ET901638.7372
10:28 ET478838.76
10:30 ET939938.7125
10:32 ET664038.4763
10:33 ET220038.37
10:35 ET1753238.215
10:37 ET1080737.96
10:39 ET469837.915
10:42 ET20037.845
10:44 ET115037.88
10:46 ET110037.695
10:48 ET719637.41
10:50 ET140037.45
10:51 ET484137.61
10:53 ET510437.59
10:55 ET630037.74
10:57 ET1000037.75
11:00 ET90037.76
11:04 ET840037.92
11:06 ET191638.055
11:08 ET932438.275
11:09 ET50038.4
11:11 ET432638.45
11:13 ET470738.46
11:15 ET1098338.46
11:18 ET694238.57
11:20 ET240038.475
11:24 ET287438.525
11:26 ET200038.46
11:27 ET50038.45
11:29 ET470038.595
11:31 ET578838.805
11:33 ET360038.85
11:36 ET110038.85
11:38 ET228038.925
11:40 ET285038.935
11:42 ET180039
11:44 ET120038.95
11:45 ET990038.905
11:47 ET50038.87
11:49 ET138838.885
11:51 ET205038.96
11:54 ET1060039.02
11:56 ET506438.915
11:58 ET57938.9726
12:02 ET30038.955
12:03 ET10038.885
12:05 ET100038.88
12:07 ET20038.8
12:09 ET319538.56
12:12 ET50038.62
12:14 ET50038.56
12:16 ET120038.67
12:18 ET20038.615
12:20 ET320238.625
12:21 ET100038.625
12:23 ET280038.46
12:25 ET520238.4
12:27 ET745238.61
12:30 ET50038.675
12:32 ET200038.71
12:34 ET463238.93
12:38 ET50038.91
12:39 ET230438.89
12:41 ET376938.65
12:43 ET10038.67
12:45 ET30038.63
12:48 ET10038.6
12:50 ET225338.69
12:52 ET70038.5805
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesXENE
Xenon Pharmaceuticals Inc
2.4B
-22.5x
---
United StatesSAGE
SAGE Therapeutics Inc
2.5B
-5.0x
---
United StatesALLO
Allogene Therapeutics Inc
2.3B
-7.6x
---
United StatesRVMD
Revolution Medicines Inc
2.1B
-8.6x
---
United StatesIMCR
Immunocore Holdings PLC
2.4B
-16.2x
---
United StatesRLAY
Relay Therapeutics Inc
2.2B
-7.8x
---
As of 2022-08-16

Company Information

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company is focused on advancing its ion channel neurology pipeline. The Company's products within its novel proprietary pipeline include clinical-stage candidates XEN496 and XEN1101, which are focused on treating neurological disorders, with a particular focus on epilepsy. XEN1101 is a differentiated Kv7 potassium channel opener being developed for the treatment of epilepsy and major depressive disorder (MDD). The XEN496 is a Kv7 potassium channel opener, is a pediatric formulation of the active ingredient ezogabine being developed for the treatment of KCNQ2 developmental and epileptic encephalopathy, or KCNQ2-DEE. The Company has promising partnered products within its pipelines, such as NBI-921352 with Neurocrine Biosciences and PCRX301 with Pacira BioSciences.

Contact Information

Headquarters
3650 Gilmore WayBURNABY, BC, Canada V5G 4W8
Phone
604-484-3300
Fax
604-484-3300

Executives

Executive Chairman of the Board
Simon Pimstone
President, Chief Executive Officer, Director
Ian Mortimer
Chief Financial Officer
Sherry Aulin
Executive Vice President - Drug Discovery
James Empfield
Executive Vice President - Strategy and Innovation
Robin Sherrington

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.4B
Revenue (TTM)
$21.2M
Shares Outstanding
60.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.54
EPS
$-1.72
Book Value
$10.65
P/E Ratio
-22.5x
Price/Sales (TTM)
114.2
Price/Cash Flow (TTM)
---
Operating Margin
-416.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.